136 related articles for article (PubMed ID: 3915359)
1. Modern beta-lactam antibiotics.
Sykes RB; Bonner DP; Swabb EA
Pharmacol Ther; 1985; 29(3):321-52. PubMed ID: 3915359
[No Abstract] [Full Text] [Related]
2. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
Sakamoto M; Ishikura T; Fukagawa Y
J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679
[TBL] [Abstract][Full Text] [Related]
3. The in vitro activity and beta-lactamase stability of cefpiramide compared with other beta-lactam antibiotics.
Neu HC; Chin NX
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):479-88. PubMed ID: 3877607
[TBL] [Abstract][Full Text] [Related]
4. beta-Lactam antibiotics: structural relationships affecting in vitro activity and pharmacologic properties.
Neu HC
Rev Infect Dis; 1986; 8 Suppl 3():S237-59. PubMed ID: 3529320
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in antimicrobial therapy with beta-lactam antibiotics.
Beam TR
J Med; 1983; 14(4):307-36. PubMed ID: 6368719
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of common gram negative bacilli to aminoglycosides and cephalosporins.
Patamasucon P; Kalnauwakul S; Ratamaruesa A; Silpapojakul K
J Med Assoc Thai; 1987 Sep; 70(9):511-5. PubMed ID: 3681179
[No Abstract] [Full Text] [Related]
7. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
Bastianini L; Sposini T; Bartoli A; Marconi P
Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
DeMaria A; Alvarez S; Klein JO; McCabe WR
Infection; 1980; 8 Suppl 3():S 261-7. PubMed ID: 6447671
[TBL] [Abstract][Full Text] [Related]
9. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents --special references to bacteria isolated between April 2008 and March 2009].
Shinagawa N; Hasegawa M; Hirata K; Furuhata T; Mizukuchi T; Osanai H; Yanai Y; Hata F; Sasaki K; Someya T; Harada K; Oono K; Tokita S; Nakamura M; Shibuya H; Hasegawa I; Kimura M; Oshima H; Maeda H; Mukaiya M; Kihara C; Kosho W; Hoshikawa T; Kimura H; Ushijima Y; Yae-Hoon Y; Aikawa N; Abe S; Yura J; Takeyama H; Wakasugi T; Taniguchi M; Mizuno I; Fukui T; Mashita K; Ishikawa S; Mizuno A; Moori N; Sumita N; Kubo S; Lee S; Oomura T; Kobayashi Y; Tsuji T; Yamaue H; Kawai M; Takesue Y; Tanaka N; Kimura H; Iwagaki H; Sueda T; Hiyama E; Murakami Y; Ooge H; Uemura K; Tsumura H; Yokoyama T; Takeuchi H; Tanakaya K; Yasunami Y; Ryu S
Jpn J Antibiot; 2010 Apr; 63(2):105-70. PubMed ID: 20919496
[TBL] [Abstract][Full Text] [Related]
10. Use of Michaelis-Menten kinetics in the analysis of synergism between beta-lactam antibiotics.
Hamilton-miller JM
J Theor Biol; 1971 May; 31(2):171-6. PubMed ID: 5208138
[No Abstract] [Full Text] [Related]
11. β-Lactams and β-Lactamase Inhibitors: An Overview.
Bush K; Bradford PA
Cold Spring Harb Perspect Med; 2016 Aug; 6(8):. PubMed ID: 27329032
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
Matsuo K; Uete T
Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
Goto S
Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
[TBL] [Abstract][Full Text] [Related]
14. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2003 and March 2004].
Shinagawa N; Taniguchi M; Hirata K; Katsuramaki T; Mizukuchi T; Mashita K; Ushijima Y; Ushida T; Ishikawa S; Aikawa N; Yo K; Mizuno A; Takayama T; Sato T; Kato K; Kubo S; Suehiro S; Yura J; Fujimoto M; Manabe T; Takeyama H; Tanimura H; Taniguchi K; Hasegawa M; Yamaue H; Ohnishi H; Tanaka N; Iwagaki H; Kimura H; Tsumura H; Fuchimoto S; Yokoyama T; Sueda T; Takesue Y; Takeuchi H; Yasui Y; Hiyama E; Ikeda S; Yasunami Y
Jpn J Antibiot; 2006 Apr; 59(2):72-116. PubMed ID: 16805318
[TBL] [Abstract][Full Text] [Related]
15. Part II. Introduction to the beta-lactam antibiotics.
Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
[No Abstract] [Full Text] [Related]
16. [Beta-lactamases of gram-negative bacteria and their role in resistance to betalactam antibiotics].
Turcu T; Liscă M
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1982; 27(1):1-10. PubMed ID: 6980440
[No Abstract] [Full Text] [Related]
17. Natural beta-lactam antibiotics.
Aoki H; Okuhara M
Annu Rev Microbiol; 1980; 34():159-81. PubMed ID: 7002023
[No Abstract] [Full Text] [Related]
18. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
Neu HC; Chin NX; Jules K; Labthavikul P
J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production.
Aldridge KE; Sanders CV; Lewis AC; Marier RL
J Med Microbiol; 1983 Feb; 16(1):75-82. PubMed ID: 6218305
[TBL] [Abstract][Full Text] [Related]
20. Some newer antibiotics.
Kohler RB; Wheat LJ; White AC
J Indiana State Med Assoc; 1983 Sep; 76(9):573-8. PubMed ID: 6556207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
